Wong P C, Zimmerman B G
J Pharmacol Exp Ther. 1980 Oct;215(1):104-9.
The roles of renin-angiotensin system and renal prostaglandins (PGs) in mediating the renal vasodilator response of captopril were studied in anesthetized nonhypotensive hemorrhaged dogs. Captopril administered i.v. at a dose of 0.5 mg/kg consistently increased renal blood flow (RBF) and decreased renal vascular resistance. Renal venous PGE concentration and PGE secretion rate were not changed significantly by captopril. In eight dogs, saralasin was infused continuously i.a. to the kidney for the entire experiment. Hemorrhage increased RBF and decreased blood pressure significantly in these animals. Captopril did not further increase RBF in the saralasin-treated kidney and still decreased blood pressure significantly. In hemorrhaged dogs given indomethacin, captopril increased RBF and decreased blood pressure to a similar degree as obtained in the untreated hemorrhaged dogs. These results suggest that under the conditions of these experiments the renal vasodilator effect of captopril is due to the blockade of the renin-angiotensin system and is not associated with either renal PGE release or PG-induced vasodilatation.
在麻醉的非低血压性出血犬中,研究了肾素-血管紧张素系统和肾前列腺素(PGs)在介导卡托普利肾血管舒张反应中的作用。静脉注射剂量为0.5mg/kg的卡托普利持续增加肾血流量(RBF)并降低肾血管阻力。卡托普利对肾静脉PGE浓度和PGE分泌率无明显影响。在8只犬中,整个实验过程中持续向肾脏动脉内输注沙拉新。出血使这些动物的RBF显著增加,血压显著降低。卡托普利未使沙拉新处理的肾脏的RBF进一步增加,但仍使血压显著降低。在给予吲哚美辛的出血犬中,卡托普利增加RBF并降低血压,其程度与未治疗的出血犬相似。这些结果表明,在这些实验条件下,卡托普利的肾血管舒张作用是由于肾素-血管紧张素系统的阻断,与肾PGE释放或PG诱导的血管舒张无关。